title: Array CGH as a first line diagnostic test in place of karyotyping for postnatal referrals - results from four years' clinical application for over 8,700 patients.
abstract: BACKGROUND
  Array CGH is widely used in cytogenetics centres for postnatal constitutional genome analysis, and is now recommended as a first line test in place of G-banded chromosome analysis. At our centre, first line testing by oligonucleotide array CGH for all constitutional referrals for genome imbalance has been in place since June 2008, using a patient vs patient hybridisation strategy to minimise costs.
  
  
  RESULTS
  Out of a total of 13,412 patients tested with array CGH, 8,794 (66%) had array CGH as the first line test. Referral indications for this first line group ranged from neonatal congenital anomalies through to adult neurodisabilities; 25% of these patients had CNVs either in known pathogenic regions or in other regions where imbalances have not been reported in the normal population. Of these CNVs, 46% were deletions or nullisomy, 53% were duplications or triplications, and mosaic imbalances made up the remainder; 87% were <5Mb and would likely not be detected by G-banded chromosome analysis. For cases with completed inheritance studies, 20% of imbalances were de novo.
  
  
  CONCLUSIONS
  Array CGH is a robust and cost-effective alternative to traditional cytogenetic methodology; it provides a higher diagnostic detection rate than G-banded chromosome analysis, and adds to the sum of information and understanding of the role of genomic imbalance in disease. Use of novel hybridisation strategies can reduce costs, allowing more widespread testing.
authors.affiliation: Cytogenetics Department, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK. joowook.ahn@nhs.net.
authors.forename: Joo Wook
authors.initials: JW
authors.lastname: Ahn
authors.forename: Susan
authors.initials: S
authors.lastname: Bint
authors.forename: Anne
authors.initials: A
authors.lastname: Bergbaum
authors.forename: Kathy
authors.initials: K
authors.lastname: Mann
authors.forename: Richard P
authors.initials: RP
authors.lastname: Hall
authors.forename: Caroline Mackie
authors.initials: CM
authors.lastname: Ogilvie
references.citation: Mol Cytogenet. 2011 May 09;4:12
references.pmid: 21549014
references.citation: Mol Cytogenet. 2010 Oct 13;3:19
references.pmid: 20942916
references.citation: Eur J Hum Genet. 2012 Feb;20(2):166-70
references.pmid: 21915152
references.citation: Mol Cytogenet. 2010 Apr 15;3:9
references.pmid: 20398301
references.citation: Eur J Hum Genet. 2004 Nov;12(11):907-15
references.pmid: 15292918
references.citation: Genome Res. 2010 Nov;20(11):1469-81
references.pmid: 20841430
references.citation: Eur J Med Genet. 2011 Mar-Apr;54(2):121-9
references.pmid: 21056703
references.citation: Nat Genet. 2004 Sep;36(9):949-51
references.pmid: 15286789
references.citation: J Med Genet. 2011 Aug;48(8):535-9
references.pmid: 21429933
references.citation: J Med Genet. 2009 Aug;46(8):511-23
references.pmid: 19372089
references.citation: Eur J Hum Genet. 2011 Nov;19(11):1112-3
references.pmid: 21587321
references.citation: Am J Hum Genet. 2010 May 14;86(5):749-64
references.pmid: 20466091